Senior insider sale
EVP & Chief Medical Officer at ASCENDIS PHARMA A/S — senior position signals high conviction
$1.32M
5.58K shares
What this filing means
SHU AIMEE plans to sell 5.58K shares of ASCENDIS PHARMA A/S valued at approximately $1.32M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/5/2026ACC: 0001964306-26-000151
Officer· EVP & Chief Medical Officer
Since Mar 2026
5.58K
Shares to sell
$1.32M
Approx. market value
5.58K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Warrant exercise
Cash
3/5/2026
5.58KTotal acquired5.58K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/5/2026 | Warrant exercise Cash | 5.58K | — |
| Total | 5.58K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
5.58K
Market value
$1.32M
3/5/2026
Total
Units
5.58K
Value
$1.32M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/5/2026 | 5.58K | $1.32M | NASDAQ | Planned |
| Total | 5.58K | $1.32M | ||